Mayne Pharma Group Limited

Σύμβολο: MYX.AX

ASX

6.8

AUD

Τιμή αγοράς σήμερα

  • -2.3865

    Λόγος P/E

  • -0.0091

    Δείκτης PEG

  • 578.51M

    MRK Cap

  • 0.00%

    DIV Απόδοση

Mayne Pharma Group Limited Δομή της διοίκησης

Πληροφορίες για τη διοίκηση

ΌνομαΤίτλος
Dr. Andrew O. Herdman Ph.D.Vice President of Group HR
Mr. Brenton WalterFinancial Controller
Ms. Laura LoftusAssociate Gen. Counsel & Company Sec.
Dr. Frank Casty M.D.Executive Vice President & Global Chief Medical Officer
Mr. Hemanshu N. PandyaSenior Vice President & Head of Generic Product Division
Mr. Shawn Patrick O'Brien B.ScChief Executive Officer, MD & Director
Ms. Kimberly Parker J.D.Executive Vice President & Gen. Counsel
Mr. Daniel MooreExecutive Vice President of Commercial
Mr. Aaron GrayChief Financial Officer
Mr. Brant SchofieldExecutive Vice President of Corporation Devel.
Ms. Erinn NathanielDirector of Global HR
Ms. Lisa PendleburyVice President of Investor Relations & Communications
Mr. Stefan J. CrossPres of International Operations
Mr. Gerard G. Nahum M.D.Chief Medical Officer